Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical liposomal amphotericin B vs intralesional meglumine antimoniate for cutaneous leishmaniasis
IRCT138802131871N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amphotericin b, meglumine antimoniate in cutaneous leishmaniasis (CL), sponsored by Mashhad University of Medical Sciences. Started Sep 2004; status: completed.
02
Drugs
amphotericin bmeglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT138802131871N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138802131871N1.